Reducing serum cholesterol levels in women

Roberto LozanoHospital Real Ntra Sra de Gracia, Pharmacy Department, Zaragoza, SpainDuring recent years, statins have been used to reduce serum cholesterol levels, but with conflicting results concerning the benefits obtained in women compared with men in the prevention of cardiovascular events.1 So...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Lozano R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8b893587704741398a928e0e73e825ec
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8b893587704741398a928e0e73e825ec
record_format	dspace
spelling	oai:doaj.org-article:8b893587704741398a928e0e73e825ec2021-12-02T02:46:26ZReducing serum cholesterol levels in women1176-63281178-2021https://doaj.org/article/8b893587704741398a928e0e73e825ec2012-09-01T00:00:00Zhttp://www.dovepress.com/reducing-serum-cholesterol-levels-in-women-a10978https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Roberto LozanoHospital Real Ntra Sra de Gracia, Pharmacy Department, Zaragoza, SpainDuring recent years, statins have been used to reduce serum cholesterol levels, but with conflicting results concerning the benefits obtained in women compared with men in the prevention of cardiovascular events.1 Some authors have suggested that the state of inflammation, assessed by the concentration of C-reactive protein (CRP), determines the protective vascular effects of statin therapy. It has been reported that statins might be more beneficial in people with elevated CRP levels, and may be ineffective in people with low concentrations of both CRP and low-density lipoprotein cholesterol.2 Furthermore, other authors have reported higher levels of CRP in women than in men.3Lozano RDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2012, Iss default, Pp 405-406 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Lozano R Reducing serum cholesterol levels in women
description	Roberto LozanoHospital Real Ntra Sra de Gracia, Pharmacy Department, Zaragoza, SpainDuring recent years, statins have been used to reduce serum cholesterol levels, but with conflicting results concerning the benefits obtained in women compared with men in the prevention of cardiovascular events.1 Some authors have suggested that the state of inflammation, assessed by the concentration of C-reactive protein (CRP), determines the protective vascular effects of statin therapy. It has been reported that statins might be more beneficial in people with elevated CRP levels, and may be ineffective in people with low concentrations of both CRP and low-density lipoprotein cholesterol.2 Furthermore, other authors have reported higher levels of CRP in women than in men.3
format	article
author	Lozano R
author_facet	Lozano R
author_sort	Lozano R
title	Reducing serum cholesterol levels in women
title_short	Reducing serum cholesterol levels in women
title_full	Reducing serum cholesterol levels in women
title_fullStr	Reducing serum cholesterol levels in women
title_full_unstemmed	Reducing serum cholesterol levels in women
title_sort	reducing serum cholesterol levels in women
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/8b893587704741398a928e0e73e825ec
work_keys_str_mv	AT lozanor reducingserumcholesterollevelsinwomen
_version_	1718402176689111040

Reducing serum cholesterol levels in women

Ejemplares similares